Elliott targets buybacks and strategic review at Bunzl

The activist investor built a near-5% stake and is pushing for share repurchases and a review of its North American business.

Elliott Investment Management has built a near-5% stake in British business supplies distributor Bunzl, becoming one of the largest shareholders and setting the stage for a potential campaign focused on shareholder returns and corporate strategy.

The activist investor is urging Bunzl to repurchase shares equivalent to as much as 10% of its market capitalization over the next 12 months while also conducting a strategic review of its North American operations, according to a recent Bloomberg report.

The campaign comes at a critical time for the company.

Bunzl, which distributes products ranging from food packaging and safety equipment to cleaning supplies and healthcare consumables, has long been regarded as one of the UK's most consistent compounders.

The company has completed around 200 acquisitions over the past two decades, using a highly decentralized model to build a global distribution network.

However, investor confidence was shaken last year after a profit warning linked largely to operational challenges and weaker demand in North America, its largest market.

That appears to be where Elliott sees an opportunity, with one possible outcome of a strategic review of the North American business being a separation or sale of the division.

Such a move could attract interest from private equity buyers and potentially highlight the value of assets that investors may not fully appreciate within the broader group structure.

The reported push for buybacks is equally significant, potentially boosting earnings per share significantly while signaling management’s confidence in the business.

The campaign also comes amid a broader surge in corporate activity across the UK market.

Activists and private equity firms have increasingly targeted London-listed companies, attracted by valuations that many investors view as depressed relative to international peers.

Last week, Australian healthcare group Sigma Healthcare confirmed preliminary talks to acquire pharmacy chain Boots, while energy distributor DCC agreed to engage with a takeover approach from a consortium led by KKR and Energy Capital Partners that values the company at approximately GBP5.7 billion ($7.6 billion).

Elliott itself has also recently built positions in companies including BP and the London Stock Exchange Group, where it has advocated for measures aimed at enhancing shareholder value.

The developments highlight the growing pressure on UK-listed companies to demonstrate value creation or risk becoming targets for activists and acquirers.

For Bunzl investors, the key question is whether management embraces Elliott’s proposals or seeks to defend its existing strategy.

Either way, the activist’s arrival ensures that capital allocation and the future of Bunzl’s North American operations will now be firmly in the spotlight.

Bunzl’s stock hit a high of GBP26.34 at 08:00 on Monday in London, up 3.8% from end-of-trading on Friday. The stock is up 26.5% year-to-date.

Like this article? Sign up for our free newsletter.